Sompraz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz HP ## Overview Sompraz HP is a fixed-dose combination product containing **esomeprazole**, **amoxicillin**, and **clarithromycin**. It is used for the eradication of *Helicobacter pylori* (*H. pylori*). Esomeprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics. ## Primary Indications * Eradication of *Helicobacter pylori* (*H. pylori*) in patients with peptic ulcer disease or a history of peptic ulcer disease. ## Adult Dosing **Sompraz HP** is a 7-day regimen. The typical dosing is: * One capsule (containing esomeprazole 40 mg, amoxicillin 1000 mg, clarithromycin 500 mg) **twice daily** with meals for 7 days. ## Pediatric Dosing Pediatric dosing for Sompraz HP is **not established**. Dosing for individual components would need to be calculated based on weight and the specific indication, following appropriate pediatric guidelines. ## Dose Adjustments * **Renal Impairment:** No dose adjustment is recommended for esomeprazole in mild to moderate renal impairment. Caution is advised in severe renal impairment. Amoxicillin and clarithromycin doses may require adjustment based on renal function per individual product monographs. * **Hepatic Impairment:** No dose adjustment is recommended for esomeprazole in mild to moderate hepatic impairment. Caution is advised in severe hepatic impairment. Clarithromycin dose should be reduced by 50% in patients with moderate to severe hepatic impairment. ## Contraindications * Hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or other macrolides, or penicillins. * History of severe hypersensitivity reactions to beta-lactam antibiotics. * Concomitant use with ranolazine, cisapride, dihydroergotamine, ergotamine, lovastatin, pitavastatin, simvastatin, or midazolam (due to clarithromycin component). * QT prolongation or history of QT prolongation. * Electrolyte disturbances (e.g., hypokalemia, hypomagnesemia). * Severe hepatic impairment (caution with clarithromycin). ## Adverse Effects * **Common:** Diarrhea, nausea, vomiting, abdominal pain, taste disturbance, headache, rash, fungal infections. * **Serious:** *Clostridioides difficile*-associated diarrhea (CDAD), hypersensitivity reactions (including anaphylaxis), Stevens-Johnson syndrome/toxic epidermal necrolysis, hepatic dysfunction, QT prolongation, tendon rupture (fluoroquinolones, less common with macrolides but possible). * **Specific to components:** * **Esomeprazole:** Fractures (hip, wrist, spine), low magnesium levels, Vitamin B12 deficiency. * **Amoxicillin:** Hypersensitivity, rash (especially in patients with mononucleosis). * **Clarithromycin:** Hepatotoxicity, QT prolongation, myopathy. ## Key Drug Interactions * **Esomeprazole:** May decrease absorption of drugs requiring acidic gastric pH (e.g., ketoconazole, itraconazole, posaconazole, cyanocobalamin, certain HIV protease inhibitors). May increase levels of drugs metabolized by CYP2C19 (e.g., citalopram, clopidogrel). * **Amoxicillin:** May decrease efficacy of oral contraceptives. Probenecid may increase amoxicillin levels. * **Clarithromycin:** Strong CYP3A4 inhibitor. May increase levels of drugs metabolized by CYP3A4 (e.g., warfarin, carbamazepine, cyclosporine, tacrolimus, some statins, colchicine). Avoid concomitant use with ranolazine, cisapride, dihydroergotamine, ergotamine, lovastatin, pitavastatin, simvastatin, and midazolam. ## Monitoring * Monitor for signs and symptoms of hypersensitivity reactions. * Monitor for signs of *C. difficile*-associated diarrhea. * Evaluate for *H. pylori* eradication status after treatment completion (e.g., urea breath test, stool antigen test, or biopsy). * Electrolyte levels (especially magnesium) and renal function, particularly with long-term PPI use or in patients with risk factors. * Liver function tests, especially in patients with pre-existing hepatic disease or if signs of liver injury occur. ## Clinical Pearls * This combination therapy is designed for a specific duration of treatment for *H. pylori* eradication. Completing the full course is crucial. * Ensure patients understand the timing of administration (twice daily with meals). * Counsel patients on potential side effects, especially diarrhea and allergic reactions, and when to seek medical attention. * Dosing of individual components may need to be adjusted if Sompraz HP is not used and therapy is constructed from separate agents, particularly in patients with renal or hepatic impairment. --- *Disclaimer: This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.*